255 related articles for article (PubMed ID: 11136567)
1. Cytologically benign endometrial cells in the papanicolaou smears of postmenopausal women.
Chang A; Sandweiss L; Bose S
Gynecol Oncol; 2001 Jan; 80(1):37-43. PubMed ID: 11136567
[TBL] [Abstract][Full Text] [Related]
2. Significance of benign endometrial cells in Pap smears from postmenopausal women.
Wu HH; Schuetz MJ; Cramer H
J Reprod Med; 2001 Sep; 46(9):795-8. PubMed ID: 11584479
[TBL] [Abstract][Full Text] [Related]
3. The Bethesda System 2001 recommendation for reporting of benign appearing endometrial cells in Pap tests of women age 40 years and older leads to unwarranted surveillance when followed without clinical qualifiers.
Aslan DL; Crapanzano JP; Harshan M; Erroll M; Vakil B; Pirog EC
Gynecol Oncol; 2007 Oct; 107(1):86-93. PubMed ID: 17604086
[TBL] [Abstract][Full Text] [Related]
4. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population.
Chin AB; Bristow RE; Korst LM; Walts A; Lagasse LD
Am J Obstet Gynecol; 2000 Jun; 182(6):1278-82. PubMed ID: 10871439
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of follow-up methods and results of atypical glandular cells of undetermined significance (AGUS) detected on cervicovaginal Pap smears.
Kim TJ; Kim HS; Park CT; Park IS; Hong SR; Park JS; Shim JU
Gynecol Oncol; 1999 May; 73(2):292-8. PubMed ID: 10329049
[TBL] [Abstract][Full Text] [Related]
6. Reporting normal endometrial cells in Pap smears: an outcome appraisal.
Gomez-Fernandez CR; Ganjei-Azar P; Capote-Dishaw J; Averette HE; Nadji M
Gynecol Oncol; 1999 Sep; 74(3):381-4. PubMed ID: 10479497
[TBL] [Abstract][Full Text] [Related]
7. Significance of benign endometrial cells in papanicolaou tests from women aged >or=40 years.
Thrall MJ; Kjeldahl KS; Savik K; Gulbahce HE; Pambuccian SE
Cancer; 2005 Aug; 105(4):207-16. PubMed ID: 15900572
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women.
Chhieng DC; Elgert P; Cohen JM; Cangiarella JF
Cancer; 2001 Feb; 93(1):1-7. PubMed ID: 11241259
[TBL] [Abstract][Full Text] [Related]
9. [The significance of endometrial cells in the cervical smear].
Doornewaard H; Sie-Go DM; Woudt JM; Kooijman CD
Ned Tijdschr Geneeskd; 1993 Apr; 137(17):868-72. PubMed ID: 8487901
[TBL] [Abstract][Full Text] [Related]
10. Incidence and clinical significance of morphologically benign-appearing endometrial cells in patients age 40 years or older: the impact of the 2001 Bethesda System.
Bean SM; Connolly K; Roberson J; Eltoum I; Chhieng DC
Cancer; 2006 Feb; 108(1):39-44. PubMed ID: 16329117
[TBL] [Abstract][Full Text] [Related]
11. Routine endometrial sampling of asymptomatic premenopausal women shedding normal endometrial cells in Papanicolaou tests is not cost effective.
Kapali M; Agaram NP; Dabbs D; Kanbour A; White S; Austin RM
Cancer; 2007 Feb; 111(1):26-33. PubMed ID: 17262796
[TBL] [Abstract][Full Text] [Related]
12. Cervical cytology in menopausal women at high risk for endometrial disease.
Van den Bosch T; Vandendael A; Wranz PA; Lombard CJ
Eur J Cancer Prev; 1998 Apr; 7(2):149-52. PubMed ID: 9818777
[TBL] [Abstract][Full Text] [Related]
13. Histologic implications of Pap smears classified as atypical glandular cells.
Haidopoulos DA; Stefanidis K; Rodolakis A; Pilalis A; Symiakaki I; Diakomanolis E
J Reprod Med; 2005 Jul; 50(7):539-42. PubMed ID: 16130853
[TBL] [Abstract][Full Text] [Related]
14. Reporting endometrial cells in women 40 years and older: assessing the clinical usefulness of Bethesda 2001.
Simsir A; Carter W; Elgert P; Cangiarella J
Am J Clin Pathol; 2005 Apr; 123(4):571-5. PubMed ID: 15743742
[TBL] [Abstract][Full Text] [Related]
15. Significance of "normal" endometrial cells in cervical cytology from asymptomatic postmenopausal women receiving hormone replacement therapy.
Montz FJ
Gynecol Oncol; 2001 Apr; 81(1):33-9. PubMed ID: 11277646
[TBL] [Abstract][Full Text] [Related]
16. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
Nassar A; Fleisher SR; Nasuti JF
Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
[TBL] [Abstract][Full Text] [Related]
17. Endometrial cells and the AutoPap System for primary screening of cervicovaginal Pap smears.
Walts AE; Thomas P
Diagn Cytopathol; 2002 Oct; 27(4):232-7. PubMed ID: 12357502
[TBL] [Abstract][Full Text] [Related]
18. Liquid-based Papanicolaou test (SurePath) interpretations before histologic diagnosis of endometrial hyperplasias and carcinomas: study of 272 cases classified by the 2001 Bethesda system.
Thrall M; Kjeldahl K; Gulbahce HE; Pambuccian SE
Cancer; 2007 Aug; 111(4):217-23. PubMed ID: 17599738
[TBL] [Abstract][Full Text] [Related]
19. Women with atypical glandular cells: a long-term follow-up study in a high-risk population.
Chhieng DC; Gallaspy S; Yang H; Roberson J; Eltoum I
Am J Clin Pathol; 2004 Oct; 122(4):575-9. PubMed ID: 15487456
[TBL] [Abstract][Full Text] [Related]
20. Small cells in cervical-vaginal smears of patients treated with tamoxifen.
Opjorden SL; Caudill JL; Humphrey SK; Salomão DR
Cancer; 2001 Feb; 93(1):23-8. PubMed ID: 11241262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]